ADARx Pharmaceuticals, Inc. ADRX
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -42.37% | -45.76% | |||
| Total Depreciation and Amortization | 17.41% | 40.08% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 277.51% | -9.93% | |||
| Change in Net Operating Assets | -101.09% | -183.02% | |||
| Cash from Operations | -108.67% | -78.51% | |||
| Capital Expenditure | 63.00% | 84.51% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 108.44% | 38.76% | |||
| Cash from Investing | 108.27% | 43.15% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -92.77% | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -92.77% | -- | |||
| Foreign Exchange rate Adjustments | 161.11% | 1,116.67% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -110.67% | -316.00% | |||